Loading...

Dashtipour, Khashayar

TitleAssociate Health Sciences Professor
InstitutionUniversity of California, Irvine
DepartmentPsychiatry and Human Behavior
Address1001 Health Sciences Road
CA 92697-3950
Phone(562) 826-8000
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lew MF, Brashear A, Dashtipour K, Isaacson S, Hauser RA, Maisonobe P, Snyder D, Ondo W. A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia. Int J Neurosci. 2018 Jul; 128(7):619-626. PMID: 29343142.
      View in: PubMed
    2. Dashtipour K, Tafreshi A, Adler C, Beach T, Chen X, Serrano G, Tashiro S, Wang C. Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson's Disease. Brain Sci. 2017 Jun 27; 7(7). PMID: 28653979.
      View in: PubMed
    3. Dashtipour K, Bhidayasiri R, Chen JJ, Jabbari B, Lew M, Torres-Russotto D. RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials. J Clin Mov Disord. 2017; 4:9. PMID: 28593050.
      View in: PubMed
    4. Wharen RE, Okun MS, Guthrie BL, Uitti RJ, Larson P, Foote K, Walker H, Marshall FJ, Schwalb J, Ford B, Jankovic J, Simpson R, Dashtipour K, Phibbs F, Neimat JS, Stewart RM, Peichel D, Pahwa R, Ostrem JL. Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial. Parkinsonism Relat Disord. 2017 Jul; 40:18-26. PMID: 28400200.
      View in: PubMed
    5. Esquenazi A, Alfaro A, Ayyoub Z, Charles D, Dashtipour K, Graham GD, McGuire JR, Odderson IR, Patel AT, Simpson DM. OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a Delphi Panel Approach. PM R. 2017 Oct; 9(10):960-968. PMID: 28286053.
      View in: PubMed
    6. Dashtipour K, Camba GC, Chen JJ, Walker HW, Lee MY. Poster 203 Systematic Literature Review of AbobotulinumtoxinA in Randomized, Controlled Clinical Trials for Adult Lower Limb Spasticity. PM R. 2016 Sep; 8(9S):S227-S228. PMID: 27672966.
      View in: PubMed
    7. Esquenazi A, Dashtipour K, Alfaro A, Ayyoub Z, Charles D, Graham GD, McGuire JR, Odderson IR, Patel AT, Simpson DM. Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post-Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm. PM R. 2016 Sep; 8(9S):S276. PMID: 27673106.
      View in: PubMed
    8. Peckham ME, Dashtipour K, Holshouser BA, Kani C, Boscanin A, Kani K, Harder SL. Novel Pattern of Iron Deposition in the Fascicula Nigrale in Patients with Parkinson's Disease: A Pilot Study. Radiol Res Pract. 2016; 2016:9305018. PMID: 27471601; PMCID: PMC4947660.
    9. Simpson DM, Patel AT, Alfaro A, Ayyoub Z, Charles D, Dashtipour K, Esquenazi A, Graham GD, McGuire JR, Odderson I. OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process. PM R. 2017 Feb; 9(2):136-148. PMID: 27346090.
      View in: PubMed
    10. Han Y, Stevens AL, Dashtipour K, Hauser RA, Mari Z. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia. J Neurol. 2016 Apr; 263(4):772-80. PMID: 26914922; PMCID: PMC4826665.
    11. Dashtipour K, Pedouim F. Botulinum Toxin: Preparations for Clinical Use, Immunogenicity, Side Effects, and Safety Profile. Semin Neurol. 2016 Feb; 36(1):29-33. PMID: 26866493.
      View in: PubMed
    12. Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity. Medicine (Baltimore). 2016 Jan; 95(2):e2468. PMID: 26765447; PMCID: PMC4718273.
    13. Dashtipour K, Chen JJ, Frei K, Nahab F, Tagliati M. Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm. Tremor Other Hyperkinet Mov (N Y). 2015; 5:338. PMID: 26566457; PMCID: PMC4636029.
    14. Dashtipour K, Chen JJ, Espay AJ, Mari Z, Ondo W. OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: a Systematic Literature Review. Mov Disord Clin Pract. 2016 Mar-Apr; 3(2):109-115. PMID: 27110585.
      View in: PubMed
    15. Dashtipour K, Chen JJ, Kani C, Bahjri K, Ghamsary M. Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type-B inhibitor: A Cross-Sectional, Cohort Study. Pharmacotherapy. 2015 Jul; 35(7):681-6. PMID: 26139574.
      View in: PubMed
    16. Simmons DB, Dashtipour K. The Quantitative Measurement of Reversible Acute Depression after Subthalamic Deep Brain Stimulation in a Patient with Parkinson Disease. Case Rep Neurol Med. 2015; 2015:165846. PMID: 26090244; PMCID: PMC4450288.
    17. Dashtipour K, Liu M, Kani C, Dalaie P, Obenaus A, Simmons D, Gatto NM, Zarifi M. Iron Accumulation Is Not Homogenous among Patients with Parkinson's Disease. Parkinsons Dis. 2015; 2015:324843. PMID: 25945281; PMCID: PMC4402185.
    18. Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity. Am J Phys Med Rehabil. 2015 Mar; 94(3):229-38. PMID: 25299523; PMCID: PMC4340600.
    19. Dashtipour K, Johnson E, Kani C, Kani K, Hadi E, Ghamsary M, Pezeshkian S, Chen JJ. Effect of exercise on motor and nonmotor symptoms of Parkinson's disease. Parkinsons Dis. 2015; 2015:586378. PMID: 25722915; PMCID: PMC4333331.
    20. Dashtipour K. Do genetic factors protect against Parkinson's disease? What I can learn from my healthy grandma. Med Hypotheses. 2014 Dec; 83(6):637-9. PMID: 25459129.
      View in: PubMed
    21. Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013 Nov; 28(13):1775-83. PMID: 23868503.
      View in: PubMed
    22. Chen JJ, Dashtipour K. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. Pharmacotherapy. 2013 Mar; 33(3):304-18. PMID: 23400888.
      View in: PubMed
    23. Chen JJ, Ondo WG, Dashtipour K, Swope DM. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther. 2012 Jul; 34(7):1487-504. PMID: 22749259.
      View in: PubMed
    24. Barber A, Dashtipour K. Sleep disturbances in Parkinson's disease with emphasis on rapid eye movement sleep behavior disorder. Int J Neurosci. 2012 Aug; 122(8):407-12. PMID: 22463496.
      View in: PubMed
    25. Chen JJ, Swope DM, Dashtipour K, Lyons KE. Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease. Pharmacotherapy. 2009 Dec; 29(12):1452-67. PMID: 19947805.
      View in: PubMed
    26. Chen JJ, Swope DM, Dashtipour K. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Clin Ther. 2007 Sep; 29(9):1825-49. PMID: 18035186.
      View in: PubMed
    27. Dashtipour K, Wong AM, Obenaus A, Spigelman I, Ribak CE. Temporal profile of hilar basal dendrite formation on dentate granule cells after status epilepticus. Epilepsy Res. 2003 May; 54(2-3):141-51. PMID: 12837565.
      View in: PubMed
    28. Dashtipour K, Yan XX, Dinh TT, Okazaki MM, Nadler JV, Ribak CE. Quantitative and morphological analysis of dentate granule cells with recurrent basal dendrites from normal and epileptic rats. Hippocampus. 2002; 12(2):235-44. PMID: 12000120.
      View in: PubMed
    29. Ribak CE, Dashtipour K. Neuroplasticity in the damaged dentate gyrus of the epileptic brain. Prog Brain Res. 2002; 136:319-28. PMID: 12143392.
      View in: PubMed
    Khashayar's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _